A Multi-Center 52-Week Study to Assess the Safety of an Albuterol Dry-powder Inhaler in Subjects With Asthma
Phase of Trial: Phase III
Latest Information Update: 26 May 2015
At a glance
- Drugs Salbutamol (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors Teva Pharmaceutical Industries
- 10 Dec 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 30 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 Oct 2010 New trial record